Replicel Life Sciences Inc (RP.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 413 | 221 | 34 | 24 | 2,419 |
| Marketable Securities | 17 | 17 | 17 | 29 | N/A |
| Receivables | 82 | 61 | 64 | 42 | 75 |
| TOTAL | $636 | $393 | $186 | $223 | $3,004 |
| Non-Current Assets | |||||
| PPE Net | 2 | 3 | 4 | 6 | 8 |
| Other Non-Current Assets | 160 | 195 | 231 | 190 | 215 |
| TOTAL | $163 | $199 | $235 | $196 | $223 |
| Total Assets | $798 | $592 | $421 | $419 | $3,227 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 47 | N/A | N/A |
| Other current liabilities | 689 | 611 | 518 | 449 | N/A |
| TOTAL | $2,073 | $1,674 | $2,239 | $1,449 | $1,530 |
| Non-Current Liabilities | |||||
| Long Term Debt | 41 | 34 | 29 | N/A | N/A |
| Deferred Revenues | 354 | 354 | 354 | 253 | 253 |
| Other Non-Current Liabilities | 2,993 | 3,763 | 895 | 0 | 0 |
| TOTAL | $4,641 | $5,760 | $3,243 | $1,900 | $2,152 |
| Total Liabilities | $6,713 | $7,434 | $5,482 | $3,349 | $3,683 |
| Shareholders' Equity | |||||
| Common Shares | 31,661 | 30,291 | 28,471 | 28,960 | 28,746 |
| Retained earnings | -42,975 | -42,232 | -38,158 | -36,513 | -33,559 |
| TOTAL | $-5,915 | $-6,842 | $-5,061 | $-2,930 | $-455 |
| Total Liabilities And Equity | $798 | $592 | $421 | $419 | $3,227 |